Press Releases :: Hancock Jaffe Laboratories, Inc. (HJLI)

First U.S. Patent Issues on Hancock Jaffe VenoValve

Apr 7, 2021

Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Pivotal Trial

Apr 5, 2021

Hancock Jaffe Submits IDE Application to FDA for VenoValve U.S. Pivotal Trial

Mar 8, 2021

First U.S. Patent Allowed on Hancock Jaffe VenoValve

Feb 24, 2021

Hancock Jaffe Completes $41 Million Public Offering

Feb 11, 2021

Hancock Jaffe Laboratories Announces Pricing of Upsized $36 Million Offering

Feb 9, 2021

Hancock Jaffe Concludes Successful VenoValve Pre-IDE Meeting with FDA

Jan 12, 2021

Hancock Jaffe Announces Executive Promotions

Dec 30, 2020

Hancock Jaffe Deemed Compliant With All NASDAQ Continued Listing Requirements

Dec 21, 2020

Hancock Jaffe Reports Two CoreoGraft Patients Have Reached 30 Day Milestone

Dec 16, 2020

Show / Refresh / Reset / Delete

Views until show: 5
Seconds until show: 5